世界のインターベンショナルオンコロジー市場は2023年に25億3,000万米ドルと評価され、2024年から2032年にかけて年平均成長率（CAGR）9%で成長すると予測されています。インターベンショナルオンコロジーは、がん治療における新興分野であり、高周波アブレーション（RFA）、動脈塞栓化学療法（TACE）、マイクロ波アブレーション（MWA）、凍結療法といった低侵襲技術を活用しています。これらの高度な治療法は、手術、化学療法、放射線療法といった従来のがん治療と比較して、高い精度、患者の負担軽減、そして迅速な回復期間を実現することから、注目を集めています。
市場の急速な拡大は、がん罹患率の上昇、画像誘導手技の進歩、そして低侵襲性腫瘍治療への投資増加によって牽引されています。世界保健機関（WHO）によると、2020年にはがんによる死亡者数が1,000万人に達し、世界で2番目に多い死亡原因となっています。世界中でがんによる負担が増大する中、医療提供者や企業は革新的で効果的かつ低侵襲性の治療法の開発に取り組んでいます。
AI、ロボット工学、リアルタイム画像技術のインターベンションオンコロジーへの統合は、治療効率と患者転帰のさらなる向上につながっています。Medtronic、Boston Scientific、Terumo Corporationなどの企業は、高度な腫瘍標的化およびアブレーションソリューションの研究開発に多額の投資を行っています。さらに、政府および民間による資金調達イニシアチブも市場の成長を加速させる上で重要な役割を果たしています。例えば、Royal Philipsは、IMAGIOコンソーシアムと共に、低侵襲がん治療の研究を支援するために2,597万ドルの助成金を獲得しました。このような投資は、世界中でインターベンション腫瘍学ソリューションの普及を促進すると期待されています。
北アメリカ市場は、インターベンショナルオンコロジー分野において圧倒的なシェアを占めており、2023年には世界全体の売上高の37.34%を占める見込みです。これは、大手医療機器企業の存在、医療費の高騰、そして有利な規制政策に牽引されています。アメリカでは、肝細胞がん（HCC）と肺がんの罹患率の上昇に加え、研究機関と業界リーダー間の戦略的連携により、市場が大きく成長しています。
ヨーロッパでは、がん罹患率の上昇と低侵襲治療への関心の高まりが市場の成長を牽引しています。欧州委員会によると、2022年には270万人ががんと診断され、2020年から2.3%増加しました。さらに、政府支援の資金援助プログラムや医療イニシアチブが、インターベンショナルオンコロジーの進歩を促進しています。
アジア太平洋地域は、がん発生率の高さ、医療インフラの拡大、そして政府の取り組みの増加を背景に、2024年から2032年にかけて11.55%という最も高い年平均成長率（CAGR）を達成すると予想されています。中国、インド、日本といった国々では、がん治療に特化した投資と臨床試験が急増しており、この地域は市場拡大とイノベーションのホットスポットとなっています。
目次
Table of Contents
Chapter 1. Global Interventional Oncology Market Executive Summary
1.1. Global Interventional Oncology Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Technique
1.3.2. By Procedure
1.3.3. By Application
1.3.4. By End-Use
1.4. Key Market Trends
1.5. Recession Impact Analysis
1.6. Analyst Recommendations & Conclusion
Chapter 2. Global Interventional Oncology Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply-Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand-Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Interventional Oncology Market Dynamics
3.1. Market Drivers
3.1.1. Rising Incidence of Cancer Worldwide
3.1.2. Increasing Preference for Minimally Invasive Procedures
3.1.3. Advancements in Image-Guided Therapies
3.1.4. Growing Government & Private Sector Investments in Oncology
3.2. Market Challenges
3.2.1. High Cost of Interventional Oncology Procedures
3.2.2. Limited Availability of Skilled Professionals
3.2.3. Regulatory and Reimbursement Challenges
3.3. Market Opportunities
3.3.1. Expansion of Healthcare Infrastructure in Emerging Markets
3.3.2. Development of AI & Robotics-Assisted Interventional Oncology
3.3.3. Growing Adoption of Combination Therapies
Chapter 4. Industry Analysis
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s Five Forces Model
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends in Interventional Oncology
4.6. Industry Expert Perspectives
4.7. Analyst Recommendations & Conclusion
Chapter 5. Global Interventional Oncology Market Size & Forecasts by Technique (2022-2032)
5.1. Segment Dashboard
5.2. Global Market Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Ablation Therapies
5.2.1.1. Radiofrequency Ablation (RFA)
5.2.1.2. Microwave Ablation (MWA)
5.2.1.3. Cryoablation
5.2.1.4. Laser Ablation
5.2.1.5. Irreversible Electroporation (IRE)
5.2.2. Embolization Therapies
5.2.2.1. Transarterial Chemoembolization (TACE)
5.2.2.2. Transarterial Radioembolization (TARE)
5.2.3. Biopsy Techniques
5.2.4. Targeted Therapy Delivery Systems
5.2.5. Image-Guided Procedures
Chapter 6. Global Interventional Oncology Market Size & Forecasts by Procedure (2022-2032)
6.1. Segment Dashboard
6.2. Global Market Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Tumor Ablation
6.2.2. Tumor Biopsy
6.2.3. Vascular Interventions
6.2.4. Palliative Care
Chapter 7. Global Interventional Oncology Market Size & Forecasts by Application (2022-2032)
7.1. Segment Dashboard
7.2. Global Market Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Liver Cancer
7.2.2. Lung Cancer
7.2.3. Kidney Cancer
7.2.4. Prostate Cancer
7.2.5. Breast Cancer
7.2.6. Other Cancers
Chapter 8. Global Interventional Oncology Market Size & Forecasts by End-Use (2022-2032)
8.1. Segment Dashboard
8.2. Global Market Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Hospitals
8.2.2. Specialty Clinics
8.2.3. Others
Chapter 9. Global Interventional Oncology Market Size & Forecasts by Region (2022-2032)
9.1. North America Market
9.1.1. U.S. Market
9.1.2. Canada Market
9.1.3. Mexico Market
9.2. Europe Market
9.2.1. Germany Market
9.2.2. UK Market
9.2.3. France Market
9.2.4. Italy Market
9.2.5. Spain Market
9.2.6. Denmark Market
9.2.7. Sweden Market
9.2.8. Norway Market
9.3. Asia-Pacific Market
9.3.1. China Market
9.3.2. Japan Market
9.3.3. India Market
9.3.4. South Korea Market
9.3.5. Australia Market
9.3.6. Thailand Market
9.4. Latin America Market
9.4.1. Brazil Market
9.4.2. Argentina Market
9.5. Middle East & Africa (MEA) Market
9.5.1. South Africa Market
9.5.2. Saudi Arabia Market
9.5.3. UAE Market
9.5.4. Kuwait Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Medtronic plc
10.1.2. Boston Scientific Corporation
10.1.3. Terumo Corporation
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Medtronic plc
10.3.2. Boston Scientific Corporation
10.3.3. Johnson & Johnson (Ethicon)
10.3.4. Baxter International Inc.
10.3.5. Cook Medical
10.3.6. C.R. Bard Inc. (Acquired by BD)
10.3.7. AngioDynamics Inc.
10.3.8. Stryker Corporation
10.3.9. B. Braun Melsungen AG
10.3.10. Siemens Healthineers
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
List of Tables
Global Interventional Oncology Market, Report Scope
Global Interventional Oncology Market Estimates & Forecasts by Region, 2022-2032 (USD Billion)
Global Interventional Oncology Market Estimates & Forecasts by Technique, 2022-2032 (USD Billion)
Global Interventional Oncology Market Estimates & Forecasts by Procedure, 2022-2032 (USD Billion)
Global Interventional Oncology Market Estimates & Forecasts by Application, 2022-2032 (USD Billion)
Global Interventional Oncology Market Estimates & Forecasts by End-Use, 2022-2032 (USD Billion)
North America Interventional Oncology Market, Estimates & Forecasts, 2022-2032 (USD Billion)
Europe Interventional Oncology Market, Estimates & Forecasts, 2022-2032 (USD Billion)
Asia Pacific Interventional Oncology Market, Estimates & Forecasts, 2022-2032 (USD Billion)
Latin America Interventional Oncology Market, Estimates & Forecasts, 2022-2032 (USD Billion)
Middle East & Africa Interventional Oncology Market, Estimates & Forecasts, 2022-2032 (USD Billion)
U.S. Interventional Oncology Market Estimates & Forecasts, 2022-2032 (USD Billion)
Germany Interventional Oncology Market Estimates & Forecasts, 2022-2032 (USD Billion)
China Interventional Oncology Market Estimates & Forecasts, 2022-2032 (USD Billion)
Brazil Interventional Oncology Market Estimates & Forecasts, 2022-2032 (USD Billion)
SWOT Analysis of Key Players in the Interventional Oncology Market
Competitive Landscape Analysis of Leading Companies in the Interventional Oncology Market
Key Industry Trends and Technological Advancements in Interventional Oncology
Porter’s Five Forces Analysis of the Global Interventional Oncology Market
PESTEL Analysis of the Global Interventional Oncology Market
This list is not complete; the final report contains more than 100 tables. The list may be updated in the final deliverable.
List of Figures
Global Interventional Oncology Market Research Methodology
Market Estimation Techniques for Interventional Oncology Market
Global Interventional Oncology Market Size Estimates & Forecasting Methods
Key Trends in the Global Interventional Oncology Market, 2022-2032
Growth Prospects of the Interventional Oncology Market, 2022-2032
Porter’s Five Forces Model for the Interventional Oncology Market
PESTEL Analysis of the Global Interventional Oncology Market
Value Chain Analysis of the Interventional Oncology Industry
Global Interventional Oncology Market Revenue by Technique, 2022 & 2032 (USD Billion)
Global Interventional Oncology Market Revenue by Procedure, 2022 & 2032 (USD Billion)
Global Interventional Oncology Market Revenue by Application, 2022 & 2032 (USD Billion)
Global Interventional Oncology Market Revenue by End-Use, 2022 & 2032 (USD Billion)
Regional Market Snapshot: Global Interventional Oncology Market, 2022 & 2032
North America Interventional Oncology Market Size, 2022 & 2032 (USD Billion)
Europe Interventional Oncology Market Size, 2022 & 2032 (USD Billion)
Asia Pacific Interventional Oncology Market Size, 2022 & 2032 (USD Billion)
Latin America Interventional Oncology Market Size, 2022 & 2032 (USD Billion)
Middle East & Africa Interventional Oncology Market Size, 2022 & 2032 (USD Billion)
Market Share Analysis of Key Players in the Global Interventional Oncology Market (2023)
Technological Innovations in Interventional Oncology Procedures
Disruptive Trends Shaping the Future of Interventional Oncology Market
This list is not complete; the final report contains more than 50 figures. The list may be updated in the final deliverable.
